Ensemble Docking as a Tool for the Rational Design of Peptidomimetic Staphylococcus aureus Sortase A Inhibitors
Dmitry A Shulga1, Konstantin V Kudryavtsev2
1Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1/3, 119991 Moscow, Russia.
International Journal of Molecular Sciences
|October 26, 2024
Summary
Developing novel antibacterial drugs targeting Sortase A (SrtA) is crucial. This study introduces an ensemble docking approach using molecular dynamics to improve the design of SrtA inhibitors, overcoming challenges in structure-based drug design.
Area of Science:
- Microbiology
- Drug Discovery
- Computational Chemistry
Background:
- Sortase A (SrtA) from *Staphylococcus aureus* is a key target for developing antivirulence antibacterial agents.
- SrtA inhibitors offer a promising strategy to reduce antimicrobial resistance due to less evolutionary pressure.
- Developing effective SrtA inhibitors has been challenging due to difficulties in structure-based drug design.
Purpose of the Study:
- To develop a robust computational protocol for designing novel SrtA inhibitors.
- To improve the rational design of peptidomimetic inhibitors by accurately representing SrtA conformations.
- To prioritize new peptidomimetic molecules for synthesis and testing against SrtA.
Main Methods:
- Utilized molecular dynamics simulations to extract relevant SrtA conformations.
- Employed an ensemble docking approach to model the LPRDA-SrtA complex.
- Applied the developed protocol to screen and prioritize novel peptidomimetic inhibitors.
Main Results:
- The ensemble docking protocol effectively represented diverse SrtA conformations.
- The method showed good correlation with existing experimental data.
- Identified and prioritized new peptidomimetic structures for further investigation.
Conclusions:
- The proposed ensemble docking approach enhances the rational design of SrtA inhibitors.
- This method addresses limitations in traditional structure-based drug design for SrtA.
- The findings provide a foundation for developing new antivirulence therapies against *Staphylococcus aureus*.
Related Concept Videos
Structure-Activity Relationships and Drug Design
622
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
622
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K


